MyAverix Finance
NS · Pharmaceuticals
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)
Pharmaceuticals & Biotechnology
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $15.07B, P/E ratio is 35.77, net margin is 14.9%, dividend yield is 1.09%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) — FAQ
What is Jagsonpal Pharmaceuticals Ltd's market cap?
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) has a reported market cap of $15.07B (data as of 2026-07-11).
What is JAGSNPHARM's P/E ratio?
The price-to-earnings (P/E) ratio for Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is 35.77 (data as of 2026-07-11).
Does Jagsonpal Pharmaceuticals Ltd pay a dividend?
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) shows a reported dividend yield of 1.09%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).
What sector is Jagsonpal Pharmaceuticals Ltd in?
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is JAGSNPHARM listed on?
JAGSNPHARM is listed on NS.
What is Jagsonpal Pharmaceuticals Ltd's net margin?
Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) reports a net margin of 14.9% (data as of 2026-07-11).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.